| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to medicine, particularly to a composition containing one polysaccharide having 15 to 50% of 1-6 glucosidic bonds; the reducing sugar content is less than 20%; a polydispersity index is less than 5; a molecular weight number average-mn is less than 4,500 g/mole; the composition also contains one active substance for treating stress, anxiety and depressive behaviour, sleep disorders, obsessive-compulsive neurosis, bulimia and epilepsy in humans and animals. The present invention also refers to a drug preparation based on the above composition, using the composition for producing the drug preparation and a kit for therapeutic and preventive treatment of stress, anxiety or depressive behaviour, sleep disorders, obsessive-compulsive neurosis, and epilepsy in humans and animals. n EFFECT: implementing the invention enables replacing antidepressants, thereby avoiding undesired side effects related to their absorption. n 11 cl, 4 tbl |